These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8401395)

  • 1. Metabolism of clentiazem in rats.
    Nakamura S; Sugawara Y; Fukushima T; Ito Y; Ohashi M; Takaiti O
    Biol Pharm Bull; 1993 Jul; 16(7):635-46. PubMed ID: 8401395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of diltiazem. I. Structures of new acidic and basic metabolites in rat, dog and man.
    Sugawara Y; Ohashi M; Nakamura S; Usuki S; Suzuki T; Ito Y; Kume T; Harigaya S; Nakao A; Gaino M
    J Pharmacobiodyn; 1988 Apr; 11(4):211-23. PubMed ID: 3411439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the metabolism of diltiazem in man.
    Sugihara J; Sugawara Y; Ando H; Harigaya S; Etoh A; Kohno K
    J Pharmacobiodyn; 1984 Jan; 7(1):24-32. PubMed ID: 6726609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of the metabolites of clentiazem.
    Inoue H; Nakamura S; Otsuka H; Gaino M; Harada T; Matsuki K; Takeda M
    Chem Pharm Bull (Tokyo); 1994 Jan; 42(1):167-72. PubMed ID: 8124760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of clentiazem (TA-3090) on platelet aggregation--alone and in combination with aspirin or ticlopidine.
    Odawara A; Katoh M; Karasawa T; Tamura K; Sasaki Y
    Thromb Res; 1994 Jul; 75(2):109-19. PubMed ID: 7974385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and metabolic fate of clentiazem in rats and dogs.
    Nakamura S; Sugawara Y; Fukushima T; Ito Y; Ohashi M; Takaiti O
    Biol Pharm Bull; 1993 Jul; 16(7):647-55. PubMed ID: 8401396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-related differences in the renal disposition of the acidic metabolite of clentiazem in rat.
    Hanada K; Fujisawa R; Kataoka R; Nakamura S; Ogata H
    Xenobiotica; 2001 Oct; 31(10):725-31. PubMed ID: 11695851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of diltiazem and its metabolites in dogs after oral administration of a multiparticulate sustained-release preparation.
    Murata K; Yamahara H; Noda K
    Pharm Res; 1993 Aug; 10(8):1165-8. PubMed ID: 8415402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: application to a pharmacokinetic study in healthy volunteers.
    Yeung PK; Montague TJ; Tsui B; McGregor C
    J Pharm Sci; 1989 Jul; 78(7):592-7. PubMed ID: 2778663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic fate of the new Ca++-channel blocking agent (+)-(2S,3S)-3-acetoxy-8-chloro-(2-(dimethylamino)ethyl)-2,3-dihydro- 2-(4-methoxyphenyl)-2,5-benzothiazepin-4-(5H)-one maleate. Distribution, excretion and protein binding in rats and dogs.
    Nakamura S; Ohashi M; Suzuki T; Sugawara Y; Usuki S; Takaiti O
    Arzneimittelforschung; 1989 Sep; 39(9):1100-8. PubMed ID: 2590259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic effects of a new 1,5-benzothiazepine calcium antagonist on stroke in salt-loaded stroke-prone spontaneously hypertensive rats.
    Kikkawa K; Murata S; Iwasaki H; Toriumi W; Banno K; Nagao T
    Arzneimittelforschung; 1992 Jun; 42(6):781-6. PubMed ID: 1418031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameliorating effect of clentiazem (TA-3090), a new Ca antagonist, on the impaired learning ability of poststroke SHRSP.
    Kinoshita K; Yamamura M; Matsuoka Y
    Pharmacol Biochem Behav; 1995 Apr; 50(4):509-15. PubMed ID: 7617695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous natriuretic factors. 5. Synthesis and biological activity of a natriuretic metabolite of diltiazem and its derivatives.
    Kantoci D; Murray ED; Quiggle DD; Wechter WJ
    J Med Chem; 1996 Mar; 39(6):1196-1200. PubMed ID: 8632425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes.
    Suzuki T; Kurosawa H; Naito K; Otsuka M; Ohashi M; Takaiti O
    Eur J Pharmacol; 1991 Mar; 194(2-3):195-200. PubMed ID: 2060600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W; Erlaçin S; Frankus E; Uragg H
    Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of diltiazem. II. Metabolic profile in rat, dog and man.
    Sugawara Y; Nakamura S; Usuki S; Ito Y; Suzuki T; Ohashi M; Harigaya S
    J Pharmacobiodyn; 1988 Apr; 11(4):224-33. PubMed ID: 3411440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clentiazem and diltiazem preserve endothelium-dependent relaxation following global rat heart ischemia.
    Dagenais F; Hollmann C; Buluran J; Cartier R
    Can J Cardiol; 1995 Oct; 11(9):816-22. PubMed ID: 7585280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive properties of the benzothiazepine calcium antagonists diltiazem and clentiazem, with and without cyclosporine, in heterotopic rat heart transplantation.
    Dumont L; Chen H; Daloze P; Xu D; Garceau D
    Transplantation; 1993 Jul; 56(1):181-4. PubMed ID: 8333040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of diltiazem and a new analogue, LR-A/113, in the conscious rat.
    Bernasconi R; Caliari S; Latini R; Leopaldi D; Porzio S; Salimbeni A
    Eur J Drug Metab Pharmacokinet; 1992; 17(4):269-74. PubMed ID: 1301356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive ion EI mass spectra of 2,3,5-trisubstituted-1,5-benzothiazepines, diltiazem, clentiazem and their fat-soluble metabolites.
    Sugawara Y; Nakamura S
    J Pharm Biomed Anal; 1994 Nov; 12(11):1397-409. PubMed ID: 7849135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.